Holly May

Holly May

Corporate Officer/Principal presso BIOLINERX LTD.

Patrimonio netto: - $ in data 31/05/2024

31 relazioni
Health Technology
Consumer Services

Posizioni attive di Holly May

SocietàPosizioneInizioFine
BIOLINERX LTD. Corporate Officer/Principal 16/06/2022 -

Storia della carriera di Holly May

Precedenti posizioni note di Holly May

SocietàPosizioneInizioFine
SWEDISH ORPHAN BIOVITRUM AB Vendite & Marketing 24/01/2018 01/08/2019
Sanofi-Aventis Israël Ltd. Vendite & Marketing - -
Genzyme Israel Ltd. Corporate Officer/Principal - -
Sobi, Inc. Corporate Officer/Principal - -
TECTONIC THERAPEUTIC, INC. Corporate Officer/Principal 21/10/2019 -

Formazione di Holly May

University of Miami Undergraduate Degree
University of Akron Masters Business Admin

Statistiche

Distribuzione geografica

Stati Uniti 5
Israele 4
Svezia 2

Posizioni

Corporate Officer/Principal 4
Sales & Marketing 2
Undergraduate Degree 1

Settori

Health Technology 4
Consumer Services 3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa2
SWEDISH ORPHAN BIOVITRUM AB

Health Technology

BIOLINERX LTD.

Health Technology

Aziende private4
Avrobio, Inc.
Logo Avrobio, Inc.

Avrobio, Inc.

BiotechnologyHealth Technology

AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA.

Health Technology

Sobi, Inc.

Genzyme Israel Ltd.

Sanofi-Aventis Israël Ltd.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Holly May
  4. Esperienza